Back to search
Upper Extremity Spasticity
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Upper Extremity Spasticity trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Upper Extremity Spasticity trials you may qualify forThe purpose of this study is to evaluate the efficacy, safety, and tolerability of BMS-986368 in participants with Multiple Sclerosis Spasticity
This work will examine if a technique called Transcutaneous Spinal cord stimulation (tSCS), when used with concurrent specific arm and hand exercises, helps imp…
The purpose of the study is to assess the safety and efficacy of increasing doses of IPN10200 with the aim to evaluate the Pharmacodynamics (PD) profile of IPN1…
Phase 3, open-label study to assess the efficacy and safety of a single lumbar intrathecal administration of MELPIDA in individuals with Hereditary Spastic Para…
Background Effective management of spasticity, a debilitating and challenging condition afflicting many recovering from and living with neurological conditions,…
This multicenter, randomized, double-blind, sham-controlled study is designed to evaluate the efficacy and safety of the iovera° system in subjects with upper e…
The aim of this study is to perform, in real world clinical practice, a three-dimensional assessment from patient's, caregiver's and physician's perspectives, o…
Our primary aim is to evaluate the implementation cost of a full day modified constraint induced movement therapy camp for children with hemiparesis. Participa…
Children with spastic bilateral cerebral palsy are late developers. delayed gross and fine motor development require early intervention to improve the child per…